Supernus gets $30 mln in non-dilutive royalty deal
HealthCare Royalty Partners is making a $30 million cash payment to Supernus for certain royalty and milestone rights related to the commercialization of its products. Supernus will retain full ownership of the royalty rights after a certain threshold has been reached per the terms of the agreement.





